A Fredericton-based pharmacist says people are still showing up to get vaccinated for influenza, despite recent news that ...

The American College of Physicians (ACP) issued new influenza vaccine practice points that say everyone ages 18 to 64 years who are not pregnant or immunocompromised should receive either a ...

Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by ...

The Trump administration has promised $2,000 tariff rebate checks to millions of Americans next year — but experts question whether the plan is feasible due to several major obstacles.

Merck & Co. Inc. is buying Cidara Therapeutics Inc. for $9.2 billion to acquire a late-stage flu candidate and also to outrace blockbuster Keytruda’s looming patent expiration. CD-388, Cidara’s lead ...

Global biopharmaceutical company CSL has announced plans to invest approximately US$1.5 billion in its United States ...

Danielle Smith’s triple-play on trans youth rights Alberta democracy isn’t just majority rule. It is majority rule bounded by ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

A mutated strain of the flu is surging worldwide, sparking concerns about a severe flu season in the U.S. Here's what to ...

There are reports of this strain of the flu causing more severe illness, and early data suggest that protection against the flu from previous infections or the vaccine is “suboptimal,” according to ...